117 related articles for article (PubMed ID: 7981443)
1. Monoclonal antibody BrE-3 participation in a multivariate prognostic model for infiltrating ductal carcinoma of the breast.
Chan CM; Baratta FS; Ozzello L; Ceriani RL
Breast Cancer Res Treat; 1994; 30(3):243-61. PubMed ID: 7981443
[TBL] [Abstract][Full Text] [Related]
2. Levels of expression of breast epithelial mucin detected by monoclonal antibody BrE-3 in breast-cancer prognosis.
Ceriani RL; Chan CM; Baratta FS; Ozzello L; DeRosa CM; Habif DV
Int J Cancer; 1992 May; 51(3):343-54. PubMed ID: 1592525
[TBL] [Abstract][Full Text] [Related]
3. Multivariate prognostic model for infiltrating ductal carcinoma of the breast in the axillary node-free patient.
Ceriani RL; Baratta F; Gaslonde RJ; De Rosa CM; Ozzello L
Adv Exp Med Biol; 1994; 353():155-67. PubMed ID: 7985534
[No Abstract] [Full Text] [Related]
4. A sialoglycoprotein (LEA.135) associated with favourable prognosis of patients with lymph node-negative primary breast carcinoma.
Imam SA; Chaiwun B; Wang MJ; Morris MM; Groshen SG; Neville AM; Torloni H; Cote RJ; Taylor CR
Anticancer Res; 1996; 16(5B):3043-8. PubMed ID: 8920764
[TBL] [Abstract][Full Text] [Related]
5. Prognostic value of phosphorylated HER2 in HER2-positive breast cancer patients treated with adjuvant trastuzumab.
Kurebayashi J; Kanomata N; Yamashita T; Shimo T; Mizutoh A; Moriya T; Sonoo H
Breast Cancer; 2015 May; 22(3):292-9. PubMed ID: 23749689
[TBL] [Abstract][Full Text] [Related]
6. Prognostic value of tumor-infiltrating dendritic cells expressing CD83 in human breast carcinomas.
Iwamoto M; Shinohara H; Miyamoto A; Okuzawa M; Mabuchi H; Nohara T; Gon G; Toyoda M; Tanigawa N
Int J Cancer; 2003 Mar; 104(1):92-7. PubMed ID: 12532424
[TBL] [Abstract][Full Text] [Related]
7. Prognostic significance of MUC1 epithelial mucin expression in breast cancer.
McGuckin MA; Walsh MD; Hohn BG; Ward BG; Wright RG
Hum Pathol; 1995 Apr; 26(4):432-9. PubMed ID: 7705823
[TBL] [Abstract][Full Text] [Related]
8. [Proliferation index and its prognostic value in invasive ductal breast carcinoma].
Falco M
Ann Acad Med Stetin; 2009; 55(1):22-30. PubMed ID: 20349588
[TBL] [Abstract][Full Text] [Related]
9. Fibrotic focus in invasive ductal carcinoma of the breast: a histopathological prognostic parameter for tumor recurrence and tumor death within three years after the initial operation.
Hasebe T; Tsuda H; Tsubono Y; Imoto S; Mukai K
Jpn J Cancer Res; 1997 Jun; 88(6):590-9. PubMed ID: 9263537
[TBL] [Abstract][Full Text] [Related]
10. High survivin mRNA expression is a predictor of poor prognosis in breast cancer: a comparative study at the mRNA and protein level.
Xu C; Yamamoto-Ibusuki M; Yamamoto Y; Yamamoto S; Fujiwara S; Murakami K; Okumura Y; Yamaguchi L; Fujiki Y; Iwase H
Breast Cancer; 2014 Jul; 21(4):482-90. PubMed ID: 22968628
[TBL] [Abstract][Full Text] [Related]
11. Immunohistochemical study of Muc1, Muc2 and human gastric mucin in breast carcinoma: relationship with prognostic factors.
Xu Y; Kimura N; Yoshida R; Lin H; Yoshinaga K
Oncol Rep; 2001; 8(5):1177-82. PubMed ID: 11496338
[TBL] [Abstract][Full Text] [Related]
12. A proposal for a new histological classification scheme for predicting short-term tumor recurrence and death in patients with invasive ductal carcinoma of the breast.
Hasebe T; Imoto S; Sasaki S; Mukai K
Jpn J Cancer Res; 1998 Dec; 89(12):1358-73. PubMed ID: 10081498
[TBL] [Abstract][Full Text] [Related]
13. Vimentin expression does not assist in predicting survival in ductal carcinoma of the breast.
Heatley MK; Ewings P; Odling Smee W; Maxwell P; Toner PG
Pathology; 2002 Jun; 34(3):230-2. PubMed ID: 12109782
[TBL] [Abstract][Full Text] [Related]
14. Prognostic significance of the immunohistochemical reaction to human milk fat globule antibodies in node-negative and node-positive breast cancer.
Sterns EE; Fletcher WA; Zee B
Breast Cancer Res Treat; 1992; 21(3):193-9. PubMed ID: 1515653
[TBL] [Abstract][Full Text] [Related]
15. Tumor angiogenesis as a prognostic assay for invasive ductal breast carcinoma.
Axelsson K; Ljung BM; Moore DH; Thor AD; Chew KL; Edgerton SM; Smith HS; Mayall BH
J Natl Cancer Inst; 1995 Jul; 87(13):997-1008. PubMed ID: 7543156
[TBL] [Abstract][Full Text] [Related]
16. Prognosis based on primary breast carcinoma instead of pathological nodal status.
Ménard S; Bufalino R; Rilke F; Cascinelli N; Veronesi U; Colnaghi MI
Br J Cancer; 1994 Oct; 70(4):709-12. PubMed ID: 7917924
[TBL] [Abstract][Full Text] [Related]
17. Expression and possible prognostic role of MAGE-A4, NY-ESO-1, and HER-2 antigens in women with relapsing invasive ductal breast cancer: retrospective immunohistochemical study.
Bandić D; Juretić A; Sarcević B; Separović V; Kujundzić-Tiljak M; Hudolin T; Spagnoli GC; Cović D; Samija M
Croat Med J; 2006 Feb; 47(1):32-41. PubMed ID: 16489695
[TBL] [Abstract][Full Text] [Related]
18. Micrometastatic breast cancer cells in bone marrow at primary surgery: prognostic value in comparison with nodal status.
Diel IJ; Kaufmann M; Costa SD; Holle R; von Minckwitz G; Solomayer EF; Kaul S; Bastert G
J Natl Cancer Inst; 1996 Nov; 88(22):1652-8. PubMed ID: 8931609
[TBL] [Abstract][Full Text] [Related]
19. Prognostic significance of vascular endothelial growth factor protein in node-negative breast carcinoma.
Gasparini G; Toi M; Gion M; Verderio P; Dittadi R; Hanatani M; Matsubara I; Vinante O; Bonoldi E; Boracchi P; Gatti C; Suzuki H; Tominaga T
J Natl Cancer Inst; 1997 Jan; 89(2):139-47. PubMed ID: 8998183
[TBL] [Abstract][Full Text] [Related]
20. Expression of c-met is a strong independent prognostic factor in breast carcinoma.
Ghoussoub RA; Dillon DA; D'Aquila T; Rimm EB; Fearon ER; Rimm DL
Cancer; 1998 Apr; 82(8):1513-20. PubMed ID: 9554529
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
